Bioworld Medtech

2 weeks ago | mddionline.com | Omar Ford |Bioworld Medtech

The diabetes management sector has emerged as one of medtech's fastest-growing segments, undergoing significant transformation compared to previous years. MD+DI has identified several pivotal partnerships that have revolutionized diabetes technology and care delivery. Diabetes tech is one of the fastest-growing segments in the medical device industry.

2 weeks ago | mddionline.com | Omar Ford |Bioworld Medtech

Personalised advertising and content, advertising and content measurement, audience research and services developmentStore and/or access information on a deviceYou can choose how your personal data is used.

3 weeks ago | mddionline.com | Omar Ford |Bioworld Medtech

Dr. Martha Morrell, CMO of NeuroPace, shares her transformative journey from medical practice to pioneering a revolutionary treatment for epilepsy. The RNS System, inspired by cardiac devices, offers targeted stimulation to the brain, tailoring interventions to each patient's needs. What is it like to go between practicing medicine and working at a startup?

3 weeks ago | mddionline.com | Omar Ford |Bioworld Medtech

Personalised advertising and content, advertising and content measurement, audience research and services developmentStore and/or access information on a deviceYou can choose how your personal data is used.

1 month ago | mddionline.com | Omar Ford |Bioworld Medtech

Pulsed-field ablation is a non-thermal method for cardiac ablation that uses strong electrical pulses to selectively destroy cardiac tissue. It is used to treat atrial fibrillation. It is also one of the hottest spaces in the cardiovascular market, garnering fierce competition among the larger strategics. Currently, Boston Scientific is being favored as a frontrunner in the space, having won approval for the Farapulse in January of 2024.